Physicians have cautioned Nigerians against dismissing the sight of blood in stool as a minor or temporary issue, warning ...

Many of the cases of colon cancer present early symptoms similar to those of IBS, or irritable bowel syndrome, since both ...

Former President Joe Biden is marking a milestone in his ongoing prostate cancer treatment. The 82-year-old Biden on Monday finished a round of radiation therapy to treat the aggressive form of cancer ...

Novartis has shared detailed data showing its radioligand therapy Pluvicto could slow the progression of certain hormone-sensitive prostate cancers ahead of a planned application with the FDA.

Those with prostate cancer that returns after surgery or radiation—and typically face a high risk of the disease spreading and death—could benefit from a new drug combination. A Cedars-Sinai Medical ...

Kentucky has long carried one of the highest burdens of colorectal cancer in the nation. For too many families, it is a diagnosis that comes too late and with too few effective treatment options. But ...

Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...

Editor’s note: This story was updated to clarify recommendations for colorectal cancer screening. As a gastroenterologist, the most meaningful part of my job is preventing colorectal cancer by ...

Thousands of claimants in the U.K. are suing Johnson & Johnson (NYSE:JNJ), accusing the healthcare giant of knowingly selling asbestos-contaminated talcum powder that allegedly caused cancer in ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about a year. This time, the drug that delivered the positive readout is Tukysa, ...

UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, pancreatic, and triple-negative breast cancers in mice—with up to 88% remaining ...